Iniziativa
One year treatment of Saxagliptin/Dapagliflozin + Metformin vs insulin glargine + metformin in subjects with Latent Autoimmune type 1 Diabetes in Adults (LADA): the “LADASaxaDapa” study
Referente attività: Raffaella Buzzetti, Ernesto Maddaloni
Area di intervento: Salute pubblica e benessere
Durata dell’iniziativa: 2024-01-01
One year treatment of Saxagliptin/Dapagliflozin + Metformin vs insulin glargine + metformin in subjects with Latent Autoimmune type 1 Diabetes in Adults (LADA): the “LADASaxaDapa” study